Filing Flows › Caribou Biosciences (CRBU) › R&D spending
Caribou Biosciences (CRBU) R&D spending by quarter
Caribou Biosciences' R&D spending was $21.3M in Q3 2026 (third quarter 2026), +13% from Q2 2026. Over the last 7 quarters it ranged from $18.9M (Q2 2026) to $35.5M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $21.3M | +13% | -5% |
| Q2 2026 | $18.9M | -8% | -32% |
| Q1 2026 | $20.6M | -13% | -42% |
| Q4 2025 | $23.8M | +6% | — |
| Q3 2025 | $22.4M | -19% | — |
| Q2 2025 | $27.7M | -22% | — |
| Q1 2025 | $35.5M | — | — |
Q3 2026 at a glance
Caribou Biosciences, Q3 2026: revenue $1.6M (-27% year over year), net loss $26.6M, operating cash flow −$22.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Caribou Biosciences' R&D spending?
Caribou Biosciences' R&D spending was $21.3M in Q3 2026 (third quarter 2026), +13% from Q2 2026.
How has Caribou Biosciences' R&D spending changed?
Over the last 7 quarters it ranged from $18.9M (Q2 2026) to $35.5M (Q1 2025).